Concepedia
Statistics
Publications
6
Citations
856
H-Index
Active since
2016
Affiliations
The Netherlands Cancer Institute(Current)
Inserm
Dana-Farber Cancer Institute
Harvard University
Université Paris Sciences et Lettres
Hatice Yücel is an author at The Netherlands Cancer Institute specializing in molecular oncology, oncology, and molecular biology.
Publications per year
2016–2025
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
Jia Zhou, Camille Gelot, Constantia Pantelidou et al. · Nature Cancer · 2021 · 337 citations · Full text
Life Sciences, Molecular Biology, Oncology +11
EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation
Beatrice Rondinelli, Ewa Gogola, Hatice Yücel et al. · Nature Cell Biology · 2017 · 329 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +12
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
Stefano Annunziato, Sjors M. Kas, Micha Nethe et al. · Genes & Development · 2016 · 149 citations · Full text
Medicine, Molecular Genetics, Oncology +14
Polymerase Theta Inhibition Kills Homologous Recombination Deficient Tumors
Jia Zhou, Camille Gelot, Constantia Pantelidou et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 17 citations · Full text
Medicine, Oncology, Pharmacology +16
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
Gerben R. Borst, Ramya Kumareswaran, Hatice Yücel et al. · Oncotarget · 2017 · 14 citations · Full text
Medicine, Oncology, Radiation Oncology +17
1–5 of 6